Entrada Therapeutics

OverviewSuggest Edit

Entrada Therapeutics is a company focusing on intracellular biologics. It utilizes its EEV technology to create a pipeline of enzyme, oligonucleotide, protein, and peptide programs to engage intracellular disease targets across both large and small therapeutics.
TypePrivate
Founded2016
HQBoston, MA, US
Websiteentradatx.com

Locations

Entrada Therapeutics is headquartered in
Boston, United States

Location Map

Latest Updates

Employees (est.) (Oct 2021)86(+5%)
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Entrada Therapeutics

Dipal Doshi

Dipal Doshi

President and Chief Executive Officer, Director
Nathan J. Dowden

Nathan J. Dowden

Chief Operating Officer
Natarajan Sethuraman

Natarajan Sethuraman

Chief Scientific Officer
Kush M. Parmar

Kush M. Parmar

Director
Nerissa C. Kreher

Nerissa C. Kreher

Chief Medical Officer
Todd Foley

Todd Foley

Director
Show more

Entrada Therapeutics Office Locations

Entrada Therapeutics has an office in Boston
Boston, MA, US (HQ)
6 Tide St
Show all (1)

Entrada Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

Entrada Therapeutics total Funding

$175.6 m

Entrada Therapeutics latest funding size

$116 m

Time since last funding

7 months ago

Entrada Therapeutics investors

Entrada Therapeutics's latest funding round in March 2021 was reported to be $116 m. In total, Entrada Therapeutics has raised $175.6 m
Show all financial metrics

Entrada Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

C

70/100

SecurityScorecard logo

Entrada Therapeutics Online and Social Media Presence

Embed Graph

Entrada Therapeutics Frequently Asked Questions

  • When was Entrada Therapeutics founded?

    Entrada Therapeutics was founded in 2016.

  • Who are Entrada Therapeutics key executives?

    Entrada Therapeutics's key executives are Dipal Doshi, Nathan J. Dowden and Natarajan Sethuraman.

  • How many employees does Entrada Therapeutics have?

    Entrada Therapeutics has 86 employees.

  • Who are Entrada Therapeutics competitors?

    Competitors of Entrada Therapeutics include Neopharmed Gentili, Macopharma and Alexion Pharmaceuticals.

  • Where is Entrada Therapeutics headquarters?

    Entrada Therapeutics headquarters is located at 6 Tide St, Boston.

  • Where are Entrada Therapeutics offices?

    Entrada Therapeutics has an office in Boston.

  • How many offices does Entrada Therapeutics have?

    Entrada Therapeutics has 1 office.